| Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? F Cicchetti, J Drouin-Ouellet, RE Gross Trends in pharmacological sciences 30 (9), 475-483, 2009 | 397 | 2009 |
| Cell-based therapies for Parkinson disease—past insights and future potential RA Barker, J Drouin-Ouellet, M Parmar Nature Reviews Neurology 11 (9), 492-503, 2015 | 346 | 2015 |
| Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling JF Poulin, J Zou, J Drouin-Ouellet, KYA Kim, F Cicchetti, RB Awatramani Cell reports 9 (3), 930-943, 2014 | 306 | 2014 |
| Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology J Drouin‐Ouellet, SJ Sawiak, G Cisbani, M Lagacé, WL Kuan, ... Annals of neurology 78 (2), 160-177, 2015 | 260 | 2015 |
| Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood–brain barrier I St-Amour, I Paré, W Alata, K Coulombe, C Ringuette-Goulet, ... Journal of Cerebral Blood Flow & Metabolism 33 (12), 1983-1992, 2013 | 171 | 2013 |
| The role of tau in the pathological process and clinical expression of Huntington’s disease R Vuono, S Winder-Rhodes, R De Silva, G Cisbani, J Drouin-Ouellet, ... Brain 138 (7), 1907-1918, 2015 | 144 | 2015 |
| The role of tau in the pathological process and clinical expression of Huntington’s disease R Vuono, S Winder-Rhodes, R De Silva, G Cisbani, J Drouin-Ouellet, ... Brain 138 (7), 1907-1918, 2015 | 144 | 2015 |
| Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson’s disease J Drouin-Ouellet, I St-Amour, M Saint-Pierre, J Lamontagne-Proulx, J Kriz, ... International Journal of Neuropsychopharmacology 18 (6), pyu103, 2015 | 141 | 2015 |
| REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and‐independent pathways J Drouin‐Ouellet, S Lau, PL Brattås, D Rylander Ottosson, K Pircs, ... EMBO molecular medicine 9 (8), 1117-1131, 2017 | 104 | 2017 |
| Inflammation and neurodegeneration: the story ‘retolled’ J Drouin-Ouellet, F Cicchetti Trends in pharmacological sciences 33 (10), 542-551, 2012 | 91 | 2012 |
| Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions J Drouin‐Ouellet, AL Brownell, M Saint‐Pierre, C Fasano, V Emond, ... Glia 59 (2), 188-199, 2011 | 80 | 2011 |
| GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington’s disease: involvement of astrocyte–neuron interactions F L'episcopo, J Drouin-Ouellet, C Tirolo, A Pulvirenti, R Giugno, N Testa, ... Cell death & disease 7 (4), e2206-e2206, 2016 | 79 | 2016 |
| Dopamine and Huntington’s disease LC Schwab, SN Garas, J Drouin-Ouellet, SL Mason, SR Stott, RA Barker Expert review of neurotherapeutics 15 (4), 445-458, 2015 | 66 | 2015 |
| Dopamine and Huntington’s disease LC Schwab, SN Garas, J Drouin-Ouellet, SL Mason, SR Stott, RA Barker Expert review of neurotherapeutics 15 (4), 445-458, 2015 | 66 | 2015 |
| Impaired thermoregulation and beneficial effects of thermoneutrality in the 3× Tg-AD model of Alzheimer's disease M Vandal, PJ White, M Tournissac, C Tremblay, I St-Amour, ... Neurobiology of aging 43, 47-57, 2016 | 62 | 2016 |
| Direct neuronal reprogramming for disease modeling studies using patient-derived neurons: what have we learned? J Drouin-Ouellet, K Pircs, RA Barker, J Jakobsson, M Parmar Frontiers in Neuroscience 11, 298468, 2017 | 60 | 2017 |
| The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity M Cote, J Drouin-Ouellet, F Cicchetti, D Soulet Brain, behavior, and immunity 25 (6), 1143-1152, 2011 | 55 | 2011 |
| The Quebec Parkinson network: a researcher-patient matching platform and multimodal biorepository Z Gan-Or, T Rao, E Leveille, C Degroot, S Chouinard, F Cicchetti, ... Journal of Parkinson's disease 10 (1), 301-313, 2020 | 42 | 2020 |
| Cell‐based therapy for Parkinson's disease: A journey through decades toward the light side of the Force M Parmar, O Torper, J Drouin‐Ouellet European Journal of Neuroscience 49 (4), 463-471, 2019 | 41 | 2019 |
| The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration J Drouin-Ouellet, C Gibrat, M Bousquet, F Calon, J Kriz, F Cicchetti Journal of neuroinflammation 8, 1-12, 2011 | 41 | 2011 |
